Skip to main content
Download PDF

Significant association between rs28362491 polymorphism in NF-κB1 gene and coronary artery disease: a meta-analysis

BMC Cardiovascular Disorders volume 20, Article number: 278 (2020) Cite this article

Abstract

Background

The association of rs28362491 polymorphism in NF-κB1 gene and coronary artery disease (CAD) risk was reported in several studies with inconsistent outcomes. This study aimed to comprehensively collect and synthesize the existing evidence to appraise whether rs28362491 was correlated to CAD susceptibility.

Methods

Databases of Web of Science, EMBASE, PubMed, Wanfang, and CNKI were retrieved from inception to August 1, 2019 without any restriction on language. The strengths of association between rs28362491 polymorphism and CAD were presented as odds ratios (ORs) and 95% confidence intervals (CIs).

Results

Thirteen case-control studies with 17 individual cohorts containing 9378 cases and 10,738 controls were incorporated into this meta-analysis. The findings indicated that rs28362491 polymorphism was significantly correlated to CAD risk in five genetic models: D vs. I, OR = 1.16, 95%CI 1.11–1.21, P<0.01; DD vs. II, OR = 1.37, 95%CI 1.25–1.49, P<0.01; DI vs. II, OR = 1.11, 95%CI 1.05–1.18, P<0.01; DD + DI vs. II, OR = 1.17, 95%CI 1.11–1.24, P<0.01; DD vs. DI + II, OR = 1.29, 95%CI 1.15–1.43, P<0.01. After stratification by ethnicity and gender, significant association still existed between rs28362491 and CAD, especially in the dominant model.

Conclusions

The findings suggest that the mutant D allele in rs28362491 locus may increase the risk of CAD, and carriers of D allele appear to be more susceptible to CAD.

Peer Review reports

Background

Coronary artery disease (CAD), which consists of clinical manifestations including stable or unstable angina, myocardial infarction, and sudden coronary death, is a leading cause of disability and death worldwide [1, 2]. The prevalence of CAD is reported to be 4.6–9.2% in the overall population, and 11.3–31.3% among the elderly aged over 65 [3]. Due to its high prevalence and incapacity, CAD has become a major health concern and imposed a heavy burden on society [2, 4].

A range of environmental factors like smoking [5], unhealthy diet and lifestyle [6], lack of physical activity [7], and low socioeconomic status [8], have been reported to stimulate the occurrence and progression of CAD. The large majority of CAD, nevertheless, are multifactorial with both environmental and heritable contributions [9]. Familial aggregation of CAD has been observed for a long time, and overwhelming evidence indicated the genetic predisposition to CAD [10, 11]. Twin studies revealed the heritability estimates for CAD ranged from 41 to 77% [12]. The importance of genetic factors in CAD resulted in extensive identification of considerable candidate genes and numerous single-nucleotide polymorphisms (SNPs) that were related to this condition [13].

Nuclear factor-κB (NF-κB) is a cluster of ubiquitous transcription factors. In the NF-κB family, there are five members including NF-κB1, RelA, c-Rel, RelB, and NF-κB2. As a fundamental transcription regulator, NF-κB participates in most biological processes. The NF-κB signaling pathway also plays a crucial role in heart diseases [14]. NF-κB1 is encoded by NF-κB1 gene, which is mapped to chromosome 4q24. Rs28362491 polymorphism is a 4 bp ATTG insertion/deletion variation in -94 bp of NF-κB1 promoter. This polymorphic site was reported to have great impact on the expression of NF-κB1 gene, with the deletion of ATTG causing reduced promoter activity.

Xie et al. [15] initially reported the correlation between rs28362491 polymorphism and risk of CAD in a Chinese cohort, investigators attempted to conduct replicate studies in different populations with inconsistent results. The conflicting findings might ascribe to small sample size and weak statistical power of an individual study. Therefore, we carried out this meta-analysis to obtain more convincing evidence on the association of rs28362491 polymorphism and CAD susceptibility.

Methods

Search strategy of literature

We searched databases of Web of Science, EMBASE, PubMed, Wanfang, and CNKI before August 1, 2019. For PubMed database, the search string was (“Polymorphism, Genetic”[Mesh] OR polymorphism OR Single Nucleotide Polymorphism OR Genetic Polymorphism OR Mutant OR Variant) AND (“NF-kappa B p50 Subunit”[Mesh] OR NFKB1 OR NF-kappa B p50 Subunit OR NF-κB1 OR NF-kappa B p50 OR NF kappa B p50) AND (Acute coronary syndrome OR Coronary Artery Disease OR Coronary Arteriosclerosis OR Coronary Atherosclerosis OR “Coronary Artery Disease”[Mesh]). No language restriction was set during the literature search process. The reference lists of relevant studies were manually examined to obtain more publications.

Inclusion and exclusion criteria

Identified studies met the following criteria were included: (i) case-control or cohort studies investigating rs28362491 and CAD; (ii) confirmed diagnosis of CAD for cases; (iii) studies with available data to calculate odds ratios (ORs) and 95% confidence intervals (95%CIs); (iv) studies that conformed to Hardy-Weinberg equilibrium (HWE) [16]. Accordingly, editorial, review, conference abstract, and animal study were excluded.

Quality assessment

Quality assessment was carried out by two investigators independently (YW and BW) based upon Newcastle-Ottawa Scale (NOS) [17]. The quality of each study was judged by three aspects including selection (4 items), comparability (2 items), and exposure (3 items). Scores of 0–3, 4–6, and 7–9 suggested low-, moderate-, and high-quality, respectively.

Data extraction

The following data were collected by two investigators independently (YW and BW): (i) first author; (ii) date of publication; (iii) nationality of participants; (iv) ethnicity; (v) gender; (vi) sample size; (vii) genotype distribution; (viii) results of HWE test. Any disagreement was resolved until reaching a consensus.

Statistical analysis

The association of rs28362491 polymorphism and CAD risk was presented as ORs and 95%CIs in allelic model (D vs. I), homozygous model (DD vs. II), heterozygous model (DI vs. II), dominant model (DD + DI vs. II), and recessive model (DD vs. DI + II). Q-statistical test and I2 test were used to examine the between-study heterogeneity. P < 0.1 and I2 > 50% indicated the heterogeneity was considerable, and a random-effects model should be applied, otherwise a fixed-effects model could be employed. Subgroup-analyses by ethnicity and gender were performed to test if there were ethnicity-specific and gender-specific effects. The data analyses were accomplished using RevMan 5.3 software.

Sensitivity analysis and publication bias

Stability of the pooled results was detected through sensitivity analysis by removing each dataset in turn and recalculating the effect sizes. Publication bias was examined by funnel plots.

Results

Literature search

Ninety-six items were obtained after the search of five databanks and reference lists of relevant studies. Thirty-nine items were deleted because of duplication. Of the remaining 57 items, 40 obviously irrelevant citations were removed after the screen of titles and abstracts. After that, another four ineligible articles were deleted after comprehensive assessment. Finally, 13 studies with 17 individual cohorts were included in the final meta-analysis. The procedures of literature search and selection were displayed in Fig. 1.

Fig. 1
figure 1

Flow chart of literature search and screen

Full size image

Main characteristics

Main characteristics of the eligible studies were summarized in Table 1. Thirteen studies [15, 18,19,20,21,22,23,24,25,26,27,28,29] with 17 individual cohorts containing 9378 cases and 10,738 controls were incorporated into this meta-analysis. Of them, 11 studies [19,20,21,22,23,24,25,26,27,28,29] were published in English and the rest two studies [15, 18] were in Chinese. The studies by Yang et al. [26], Stegger et al. [28], and Mishra et al. [29] consisted of two, three, and two individual cohorts, respectively. The included studies were conducted in different countries including China, Iran, Spain, Turkey, Denmark, USA, and India. Of note, the diagnosis of CAD was through coronary angiography by all included study with the exception of Stegger et al. [28], in which CAD was defined as unstable angina pectoris, myocardial infarction, and fatal coronary heart disease. All the studies conformed to HWE. In the light of NOS, all eligible studies obtained 5 to 9 stars, indicating a moderate to high quality (Table 2).

Table 1 Main characteristics of included studies
Full size table
Table 2 Quality assessment of included studies according to the Newcastle-Ottawa Scale
Full size table

Meta-analysis and subgroup-analysis

Results of overall and subgroup analyses were summarized in Table 3. For the overall populations, between-study heterogeneity was observed in recessive model, and the random-effects model was employed. For the rest contrasts, little heterogeneity was found and the fixed-effects model was used. The pooled data indicated that rs28362491 was significantly associated with increased risk of CAD under all five genetic models: D vs. I, OR = 1.16, 95%CI 1.11–1.21, P<0.01 (Fig. 2); DD vs. II, OR = 1.37, 95%CI 1.25–1.49, P<0.01; DI vs. II, OR = 1.11, 95%CI 1.05–1.18, P<0.01; DD + DI vs. II, OR = 1.17, 95%CI 1.11–1.24, P<0.01; DD vs. DI + II, OR = 1.29, 95%CI 1.15–1.43, P<0.01.

Table 3 Association between rs28362491 polymorphism and coronary artery disease
Full size table
Fig. 2
figure 2

Forest plot of association between rs28362491 and coronary artery disease in allelic model

Full size image

Subgroup analysis by ethnicity revealed that rs28362491 was significantly associated with an increased CAD risk in Asians under five genetic models: D vs. I, OR = 1.21, 95%CI 1.15–1.27, P<0.01; DD vs. II, OR = 1.50, 95%CI 1.35–1.67, P<0.01; DI vs. II, OR = 1.11, 95%CI 1.03–1.20, P<0.01; DD + DI vs. II, OR = 1.20, 95%CI 1.12–1.28, P<0.01; DD vs. DI + II, OR = 1.43, 95%CI 1.30–1.57, P<0.01. While, for the Caucasian population, only marginally positive associations were witnessed in heterozygous model (DI vs. II, OR = 1.12, 95%CI 1.00–1.25, P = 0.05) and dominant model (DD + DI vs. II, OR = 1.12, 95%CI 1.00–1.24, P = 0.04), and no association was observed under other contrasts.

Further subgroup analysis by gender demonstrated that rs28362491 was significantly associated with an increased risk of CAD in females under allelic model (D vs. I, OR = 1.14, 95%CI 1.06–1.24, P<0.01), homozygous model (DD vs. II, OR = 1.37, 95%CI 1.16–1.61, P<0.01), dominant model (DD + DI vs. II, OR = 1.13, 95%CI 1.01–1.26, P = 0.04), and recessive model (DD vs. DI + II, OR = 1.37, 95%CI 1.08–1.73, P<0.01). When it came to males, significant associations were found under allelic model (D vs. I, OR = 1.16, 95%CI 1.05–1.27, P<0.01), homozygous model (DD vs. II, OR = 1.30, 95%CI 1.07–1.60, P = 0.01), heterozygous model (DI vs. II, OR = 1.18, 95%CI 1.04–1.34, P<0.01), and dominant model (DD + DI vs. II, OR = 1.21, 95%CI 1.07–1.37, P<0.01).

Sensitivity analysis and publication bias

After removal of each study, the re-calculated effect sizes did not reverse, which confirmed the stability and reliability of our findings. Visual inspection of funnel plots did not identify obvious asymmetry, indicating the outcomes were unlikely to have severe publication bias (Fig. 3).

Fig. 3
figure 3

Funnel plot of association between rs28362491 and coronary artery disease

Full size image

Discussion

CAD causes nearly one-third of all deaths in individuals aged over 35 [30]. However, the etiology of CAD remains far from clear. Knowledge of the etiology behind CAD can lead to early preventative modifications and improved therapeutics of this disease. Similar to most diseases, CAD is also a multifactorial disorder. In the past decade, genetic factors were recognized to make substantial contribution to CAD vulnerability and received much more attentions. Genome-wide association studies and case-control studies have recognized considerable genes and polymorphic loci that are associated with CAD risk [13, 31]. Rs28362491 polymorphism in NF-κB1 gene is one of the most widely studied locus.

Studies on the association of rs28362491 polymorphism and CAD predisposition have been carried out in different regions. However, it is quite regrettable that those studies reported inconsistent findings and more convincing evidence remains to be determined. By merging the data from previous studies, this meta-analysis indicated that rs28362491 was significantly associated with CAD. The findings of subgroup-analyses witnessed that rs28362491 was significantly associated with CAD in dominant comparison, regardless of ethnicity and gender. Of note, in the Caucasian population, the association was of borderline significance, which might be attributable to limited sample size of participants. In addition, the trends of associations in different genders were not always consistent, which might be caused by gender differences of genotype distributions.

NF-κB is a pleiotropic transcription regulator implicating in diverse biological process including cell proliferation, differentiation, adhesion, and apoptosis, thus exerting crucial effects on multiple pathological states like inflammatory response, which plays a vital role in the development of CAD [32]. Despite different dimeric forms of NF-κB have been reported, NF-κB1 and RelA are the most extensively studied isoforms [33]. NF-κB1 gene encodes a non-DNA-binding cytoplasmic protein (p105) and a DNA-binding protein (p50) that bind to N-terminus of p105 [34]. Campbell et al. [35] reported that p50 homodimers could impede p65 dimers from combining to promoters and activating genes involved in inflammatory response. The p50 homodimers also promoted the transcription of pro-inflammatory cytokines and inhibited the transcription of anti-inflammatory cytokines.

Rs28362491 polymorphism is located between two putative key promoter regulatory elements of NF-κB1 gene. This polymorphic site consists of three genotypes, namely mutant homozygous DD (deletion/deletion), heterozygous DI (deletion/insertion), and wild homozygous II (insertion/insertion) [36]. Park et al. found that individuals with DD homozygous genotype have lower activated NF-κB [37]. Additionally, compared with II homozygous endothelial cells, DD homozygous cells appeared to have a lower increase in eNOS protein level under unidirectional laminar shear stress [37]. Fontaine-Bisson et al. [38] observed that D allele of rs28362491 was associated with higher level of C-reactive protein, which was an established risk indicator for cardiovascular disease. The in vitro study revealed that the D allele in rs28362491 polymorphism might result in reduced NF-κB1 message, thus decreasing the expression of NF-κB1 [39]. The NF-κB1 appears to be specifically involved in anti-inflammatory effects, and decreased NF-κB1 can promote the transcription of pro-inflammatory cytokines like TNF-α and IL-12 [40], which are contributors of CAD [41, 42].

The findings of this study could contribute to a broader recognition of the genetic architecture of CAD. In the near future, with the enhanced understanding of genetics, evidence from the genetic studies may have the capacity to improve healthcare of an individual with CAD by taking preventive measures, offering accurate diagnosis, as well as providing personalized treatment. Additionally, appropriate screening programs can be carried out for an individual with a first-degree relative has a history of CAD. Genetic studies may serve to recognize genes as potential therapeutic targets.

It was noted that Chen et al. [43] had published a similar meta-analysis in 2014. Nevertheless, the current study has notable advantages. First, several newly published papers [18,19,20,21,22, 24, 25] were included in our study, and the number of included studies and participants were greatly enlarged. Second, a more comprehensive search strategy was employed to obtain relevant studies at a maximum. Third, we adopt a more strict inclusion and exclusion criteria, and excluded Lopez-Mejias et al.’s study [44], of which cardiovascular disease was considered to be equal to CAD by Chen et al. [43]. Fourth, sensitive analysis was conducted to check the stability of the outcomes. Consequently, these advantages strongly guaranteed a more accurate and reliable conclusion.

Inevitably, this study had several drawbacks. First, the effect sizes were based on unadjusted evaluation for lack of sufficient data, and failure to perform further adjusted analyses might influence the reliability of those findings. Second, like most disease, CAD is a multi-factorial disorder that is associated with genetic and environmental factors. Nevertheless, owing to lack of detailed data in primary studies, we were unable to evaluate the effects of multi-factor interactions. Third, the included populations were from Asian and Caucasian populations, ethnicity bias might exist in our analysis. Thus, the findings might not be applicable to other populations. Last, only three English databases and two Chinese databases were retrieved for potentially relevant studies, although no obvious dissymmetry in any funnel plot was observed, publication biases might exist which could influence the results.

Conclusion

The current study indicates that the mutant D allele in rs28362491 locus may increase the risk of CAD, and carriers of D allele appear to be more susceptible to CAD. Due to limitations of this study, the association between rs28362491 polymorphism and CAD could not be entirely concluded. Further well-designed studies among different ethnicities are still warranted to confirm our findings.

Availability of data and materials

Available upon request to the corresponding author Jiaan Sun, jiaansun@126.com

Abbreviations

CAD:

Coronary artery disease

OR:

Odds ratio

CI:

Confidence interval

HWE:

Hardy-Weinberg equilibrium

NOS:

Newcastle-Ottawa scale

References

  1. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke Statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492.

    Article  PubMed  Google Scholar 

  2. Leong DP, Joseph PG, McKee M, Anand SS, Teo KK, Schwalm JD, et al. Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease. Circ Res. 2017;121(6):695–710.

    Article  CAS  PubMed  Google Scholar 

  3. Zhu KF, Wang YM, Zhu JZ, Zhou QY, Wang NF. National prevalence of coronary heart disease and its relationship with human development index: a systematic review. Eur J Prev Cardiol. 2016;23(5):530–43.

    Article  PubMed  Google Scholar 

  4. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 2010;35(2):72–115.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Zhu J, Nelson K, Toth J, Muscat JE. Nicotine dependence as an independent risk factor for atherosclerosis in the National Lung Screening Trial. BMC Public Health. 2019;19(1):103.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343(1):16–22.

    Article  CAS  PubMed  Google Scholar 

  7. Huxley RR, Misialek JR, Agarwal SK, Loehr LR, Soliman EZ, Chen LY, et al. Physical activity, obesity, weight change, and risk of atrial fibrillation: the atherosclerosis risk in communities study. Circ Arrhythm Electrophysiol. 2014;7(4):620–5.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kollia N, Panagiotakos DB, Georgousopoulou E, Chrysohoou C, Tousoulis D, Stefanadis C, et al. Exploring the association between low socioeconomic status and cardiovascular disease risk in healthy Greeks, in the years of financial crisis (2002-2012): the ATTICA study. Int J Cardiol. 2016;223:758–63.

    Article  PubMed  Google Scholar 

  9. Said MA, Verweij N, van der Harst P. Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK biobank study. JAMA Cardiol. 2018;3(8):693–702.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Mayer B, Erdmann J, Schunkert H. Genetics and heritability of coronary artery disease and myocardial infarction. Clin Res Cardiol. 2007;96(1):1–7.

    Article  PubMed  Google Scholar 

  11. Fischer M, Mayer B, Baessler A, Riegger G, Erdmann J, Hengstenberg C, et al. Familial aggregation of left main coronary artery disease and future risk of coronary events in asymptomatic siblings of affected patients. Eur Heart J. 2007;28(20):2432–7.

    Article  PubMed  Google Scholar 

  12. Evans A, Van Baal GC, McCarron P, DeLange M, Soerensen TI, De Geus EJ, et al. The genetics of coronary heart disease: the contribution of twin studies. Twin Res. 2003;6(5):432–41.

    Article  PubMed  Google Scholar 

  13. O'Donnell CJ, Nabel EG. Genomics of cardiovascular disease. N Engl J Med. 2011;365(22):2098–109.

    Article  CAS  PubMed  Google Scholar 

  14. Dhingra R, Shaw JA, Aviv Y, Kirshenbaum LA. Dichotomous actions of NF-kappaB signaling pathways in heart. J Cardiovasc Transl Res. 2010;3(4):344–54.

    Article  PubMed  Google Scholar 

  15. Xie YF, Chen Z, Ma GS, Wang JH, Zhang XL. The chronic inflammation and NF-KB1 gene polymorphism in patients with chronic coronary heart disease. Journal of Clinical Emergency Call. 2008;9(6):334–6.

    Google Scholar 

  16. Ryckman K, Williams SM. Calculation and use of the hardy-Weinberg model in association studies. Curr Protoc Hum Genet. 2008;Chapter 1:Unit 1.18. https://doi.org/10.1002/0471142905.hg0118s57.

  17. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses; 2018. Available: http://www.ohrica/programs/clinical_epidemiology/oxfordasp.

    Google Scholar 

  18. Hu XJ. NFKB1 gene polymorphism and early scanning of coronary artery disease. Health Care Today. 2019;4:79–80.

    Google Scholar 

  19. Jin SY, Luo JY, Li XM, Liu F, Ma YT, Gao XM, et al. NFKB1 gene rs28362491 polymorphism is associated with the susceptibility of acute coronary syndrome. Biosci Rep. 2019;39(4):BSR20182292.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Coto E, Reguero JR, Avanzas P, Pascual I, Martin M, Hevia S, et al. Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease. Immunol Lett. 2019;208:39–43.

    Article  CAS  PubMed  Google Scholar 

  21. Seidi A, Mirzaahmadi S, Mahmoodi K, Soleiman-Soltanpour M. The association between NFKB1 -94ATTG ins/del and NFKB1A 826C/T genetic variations and coronary artery disease risk. Mol Biol Res Commun. 2018;7(1):17–24.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Luo JY, Li XM, Zhou Y, Zhao Q, Chen BD, Liu F, et al. Mutant DD genotype of NFKB1 gene is associated with the susceptibility and severity of coronary artery disease. J Mol Cell Cardiol. 2017;103:56–64.

    Article  CAS  PubMed  Google Scholar 

  23. Lai HM, Li XM, Yang YN, Ma YT, Xu R, Pan S, et al. Genetic variation in NFKB1 and NFKBIA and susceptibility to coronary artery disease in a Chinese Uygur population. PLoS One. 2015;10(6):e0129144.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Lai H, Chen Q, Li X, Ma Y, Xu R, Zhai H, et al. Association between genetic polymorphism in NFKB1 and NFKBIA and coronary artery disease in a Chinese Han population. Int J Clin Exp Med. 2015;8(11):21487–96.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Arslan S, Korkmaz O, Ozbilum N, Berkan O. Association between NF-kappaBI and NF-kappaBIA polymorphisms and coronary artery disease. Biomed Rep. 2015;3(5):736–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Yang YN, Zhang JY, Ma YT, Xie X, Li XM, Liu F, et al. 94 ATTG insertion/deletion polymorphism of the NFKB1 gene is associated with coronary artery disease in Han and Uygur women in China. Genet Test Mol Biomarkers. 2014;18(6):430–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Mishra A, Srivastava A, Mittal T, Garg N, Mittal B. Genetic predisposition to left ventricular dysfunction: a multigenic and multi-analytical approach. Gene. 2014;546(2):309–17.

    Article  CAS  PubMed  Google Scholar 

  28. Stegger JG, Schmidt EB, Berentzen TL, Tjonneland A, Vogel U, Rimm E, et al. Interaction between obesity and the NFKB1 - 94ins/delATTG promoter polymorphism in relation to incident acute coronary syndrome: a follow up study in three independent cohorts. PLoS One. 2013;8(5):e63004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Mishra A, Srivastava A, Mittal T, Garg N, Mittal B. Role of inflammatory gene polymorphisms in left ventricular dysfunction (LVD) susceptibility in coronary artery disease (CAD) patients. Cytokine. 2013;61(3):856–61.

    Article  CAS  PubMed  Google Scholar 

  30. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):256.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Abraham G, Havulinna AS, Bhalala OG, Byars SG, De Livera AM, Yetukuri L, et al. Genomic prediction of coronary heart disease. Eur Heart J. 2016;37(43):3267–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kaptoge S, Seshasai SR, Gao P, Freitag DF, Butterworth AS, Borglykke A, et al. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur Heart J. 2014;35(9):578–89.

    Article  CAS  PubMed  Google Scholar 

  33. Blank V, Kourilsky P, Israel A. NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci. 1992;17(4):135–40.

    Article  CAS  PubMed  Google Scholar 

  34. Heron E, Deloukas P, van Loon AP. The complete exon-intron structure of the 156-kb human gene NFKB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I kappa B-gamma: implications for NF-kappa B-mediated signal transduction. Genomics. 1995;30(3):493–505.

    Article  CAS  PubMed  Google Scholar 

  35. Low JT, Hughes P, Lin A, Siebenlist U, Jain R, Yaprianto K, et al. Impact of loss of NF-kappaB1, NF-kappaB2 or c-REL on SLE-like autoimmune disease and lymphadenopathy in Fas (lpr/lpr) mutant mice. Immunol Cell Biol. 2016;94(1):66–78.

    Article  CAS  PubMed  Google Scholar 

  36. Ota N, Nakajima T, Shirai Y, Emi M. Isolation and radiation hybrid mapping of a highly polymorphic CA repeat sequence at the human nuclear factor kappa-beta subunit 1 (NFKB1) locus. J Hum Genet. 1999;44(2):129–30.

    Article  CAS  PubMed  Google Scholar 

  37. Park J-Y, Farrance IKG, Fenty NM, Hagberg JM, Roth SM, Mosser DM, et al. NFKB1 promoter variation implicates shear-induced NOS3 gene expression and endothelial function in prehypertensives and stage I hypertensives. Am J Physiol Heart Circ Physiol. 2007;293(4):H2320–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Fontaine-Bisson B, Wolever TM, Connelly PW, Corey PN, El-Sohemy A. NF-kappaB -94Ins/Del ATTG polymorphism modifies the association between dietary polyunsaturated fatty acids and HDL-cholesterol in two distinct populations. Atherosclerosis. 2009;204(2):465–70.

    Article  CAS  PubMed  Google Scholar 

  39. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, Bailey-Wilson JE, et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet. 2004;13(1):35–45.

    Article  CAS  PubMed  Google Scholar 

  40. Pereira SG, Oakley F. Nuclear factor-kappaB1: regulation and function. Int J Biochem Cell Biol. 2008;40(8):1425–30.

    Article  CAS  PubMed  Google Scholar 

  41. Christodoulidis G, Vittorio TJ, Fudim M, Lerakis S, Kosmas CE. Inflammation in coronary artery disease. Cardiol Rev. 2014;22(6):279–88.

    Article  PubMed  Google Scholar 

  42. Ye J, Wang Y, Wang Z, Liu L, Yang Z, Wang M, et al. Roles and mechanisms of interleukin-12 family members in cardiovascular diseases: opportunities and challenges. Front Pharmacol. 2020;11:129.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Chen QJ, Lai HM, Zhao L, Ma YT, Li XM, Zhai H, et al. Association between the NFKB1-94ins/del ATTG polymorphism (rs28362491) and coronary artery disease: a systematic review and meta-analysis. Genet Test Mol Biomarkers. 2016;20(3):105–11.

    Article  CAS  PubMed  Google Scholar 

  44. Lopez-Mejias R, Garcia-Bermudez M, Gonzalez-Juanatey C, Castaneda S, Miranda-Filloy JA, Gomez-Vaquero C, et al. NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis. 2012;224(2):426–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Department of Cardiology, Hebei Province Hospital of Traditional Chinese Medicine, Zhongshan East street 389#,, Shijiazhuang, 050011, Changan District, China

    Yanwei Wang, Muqing Zhang, Huawei Miao & Jiaan Sun

  2. Department of Cardiology, 980 Hospital of PLA joint Logisitics Support Force, Shijiazhuang, 050000, China

    Bianwen Wu

Authors
  1. Yanwei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bianwen Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Muqing Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Huawei Miao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jiaan Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JS conceived and designed this study. YW and BW were responsible for collection of data and performing the statistical analysis and manuscript preparation. MZ and HM were responsible for checking the data. All authors were responsible for drafting the manuscript, reading and approving the final version.

Corresponding author

Correspondence to Jiaan Sun.

Ethics declarations

Ethics approval and consent to participate

Not applicable as this is a meta-analysis of previously published papers.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Y., Wu, B., Zhang, M. et al. Significant association between rs28362491 polymorphism in NF-κB1 gene and coronary artery disease: a meta-analysis. BMC Cardiovasc Disord 20, 278 (2020). https://doi.org/10.1186/s12872-020-01568-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12872-020-01568-0

Keywords

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us